Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17849000 | 0.85 | MEN1 (0.37) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL22771007 | 0.78 | PAOX (0.37) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL1026064 | 0.75 | ALDH1A1 (0.48) | MEN1KMT2A | |
| SCHEMBL14740723 | 0.75 | SAT1 (0.33) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL2721332 | 0.75 | PRMT3 (0.37) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL18783589 | 0.74 | KDM4E (0.38) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL1584251 | 0.74 | SAT1 (0.38) | MEN1HTTKMT2AL3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL13724288 | 0.74 | KDM4A (0.32) | — | |
| SCHEMBL19210479 | 0.73 | CYP2D6 (0.32) | MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL1584053 | 0.73 | POLB (0.32) | MEN1HTTKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034440-A1 | HOMOCYSTEINE SYNTHASE INHIBITOR | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-2275404-A1 | HOMOCYSTEINE SYNTHASE INHIBITOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034440-A1 | HOMOCYSTEINE SYNTHASE INHIBITOR | BHMT, CBS, BHMT2 | MEN1 514/4885HTT 172/4885KMT2A 1006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.